Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction
CONCLUSIONS: PCs serve as potential plasma biomarkers and help identify patients with HBVLD at risk of HCC who should be screened for early diagnosis and intervention.PMID:37672012 | DOI:10.1080/14737159.2023.2254884
Source: Expert Review of Molecular Diagnostics - Category: Laboratory Medicine Authors: Kang Li Wanting Shi Yi Song Lin Qin Chaoran Zang Tingting Mei Ang Li Qingkun Song Yonghong Zhang Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Laboratory Medicine | Liver | Liver Cancer | Liver Disease | Mitochondrial Disease | Urology & Nephrology